Be The First To
Amylin Pharmaceuticals helps diabetics gain the upper hand in their battle with the disease. The company makes and markets injectable diabetes drugs Byetta and Symlin, which are approved as adjunct therapies to other diabetes treatments such as metformin and insulin. Byetta is also approved as a stand-alone diabetes therapy. Amylin gained FDA approval for Bydureon, a once-weekly version of Byetta, in 2012, and it is developing additional drugs for metabolic conditions. The company's US sales force markets its products to patients and physicians; development partner Eli...
This is the employer's chance to tell you why you should work for them. The information provided is from their perspective.
Employees are “Satisfied” 79 ratings
44% of the CEO 55 ratings
President, CEO, and Director
|Salaries in USD||Avg. Salary|| |
8 Amylin Pharmaceuticals Salaries
6 Amylin Pharmaceuticals Salaries
5 Amylin Pharmaceuticals Salaries
= Salary Range
= Anonymous Salary Range
Accepted Offer – Interviewed in San Diego, CA Nov 2010 – Reviewed Apr 4, 2014
Interview Details – Several phone screens and long face to face interviews – Full Interview
Nothing was too challenging – Answer Question
Let us know if we're missing any workplace or industry recognition –